Tight Interplay Between Therapeutic Monoclonal Antibodies and the Tumour Microenvironment in Cancer Therapy.

Riller, Quentin; Varthaman, Aditi; Sibéril, Sophie

Riller, Quentin; Varthaman, Aditi; Sibéril, Sophie.

Afiliação

Riller Q; Centre de Recherche des Cordeliers, INSERM UMRS1138, Sorbonne Université, Université de Paris, Paris, France.
Varthaman A; Centre de Recherche des Cordeliers, INSERM UMRS1138, Sorbonne Université, Université de Paris, Paris, France.
Sibéril S; Centre de Recherche des Cordeliers, INSERM UMRS1138, Sorbonne Université, Université de Paris, Paris, France. sophie.siberil@sorbonne-universite.fr.

Adv Exp Med Biol ; 1277: 127-141, 2020.

Article em En | MEDLINE | ID: mdl-33119870

Assuntos

Anticorpos Monoclonais; Neoplasias/terapia; Microambiente Tumoral; Anticorpos Monoclonais/uso terapêutico; Humanos; Imunomodulação; Imunoterapia

Palavras-chave

Antibody-dependent cellular cytotoxicity; Antibody-dependent cellular phagocytosis; Bystander effects of monoclonal antibodies; Cancer therapy; Fab- and Fc-dependent mechanisms of action; Fc gamma receptors; IgG; Immune checkpoints; Immunotherapy; Innate immunity; Long-term adaptive immunity; Modulation of anti-tumour adaptive immunity; Monoclonal antibodies; Tumour microenvironment; Vaccinal effect

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Anticorpos Monoclonais / Neoplasias Limite: Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google